Patent US5362756A successfully refreshed from Google Patents.
US5362756A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Use of fedotozine in the treatment of functional states of intestinal obstructions
Assignee: Jouveinal SA
•
Filing: 1992-08-31
•
Granted: 1994-11-08
•
Expires: 2012-08-31
Abstract
Abstract A process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-1[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N dimethylpropylamine or the addition salt thereof with (-)-tartaric acid is disclosed.
Inventors
- 👤 Pierre J. M. Riviere
- 👤 Xavier B. Pascaud
- 👤 Francois J. Roman
- 👤 Jean-Louis Junien
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 08:30
CPC Classifications
C; C07; C07C; C07C217/00; C07C217/02; C07C217/48
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
26 words
Process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethylpropylamine or the addition salt thereof with (-)-tartaric acid.
Claim 2
Dependent Claim
26 words
Process for inhibiting functional ileus in a patient, which consists of administering a therapeutically effective dose of (+)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethylpropylamine or the addition salt thereof with (-)-tartaric acid.
Claim 3
Dependent Claim
12 words
Process according to claim 1, in which the functional ileus is postoperative.
Claim 4
Dependent Claim
14 words
Process according to claim 1, in which the functional ileus is of pseudo-obstructive origin.
Claim 5
Dependent Claim
20 words
Process according to claim 1 which consists in administering a daily dose of 5 to 1000 mg to the patient.
Claim 6
Dependent Claim
13 words
Process according to claim 1, which consists in administering the substance by injection.
Claim 7
Dependent Claim
13 words
Process according to claim 1, which consists in administering the substance by perfusion.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-11-07 | 1998-05-09 | 1998-11-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-11-07 | 2002-05-09 | 2002-11-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-11-07 | 2006-05-09 | 2006-11-08 | $7700.00 | Window Closed / Lapsed |